Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
migraine
Pharma
Axsome secures hard-fought FDA nod for migraine drug Symbravo
Axsome has won approval for its oral migraine drug Symbravo, which provides rapid-acting relief from acute migraine episodes.
Kevin Dunleavy
Jan 31, 2025 8:18am
Pfizer pays $60M to resolve Biohaven's Nurtec kickback claims
Jan 27, 2025 10:39am
AbbVie names first Migraine Career Catalyst Award winners
Nov 15, 2024 2:58pm
BMJ says newer migraine drugs less effective than older triptans
Sep 19, 2024 11:32am
Tonix awareness push questions efficacy of oral migraine drugs
Sep 13, 2024 7:00am
FDA slams AbbVie for misleading claims in Serena Williams ad
Sep 12, 2024 6:48am
